Lumira Ventures raises US$255M across two healthtech funds


    The Toronto-based venture capital firm raised US$220 million for its Fund IV, its largest to date, and another US$35 million for a “strategic fund” in partnership with an undisclosed international pharmaceutical company. Investors in Fund IV include Kensington Capital Partners, Northleaf Capital Partners, Teralys Capital, Fonds de solidarité FTQ, the Caisse de dépôt et placement du Québec, Business Development Bank of Canada, Investissement Québec and Vancity. (The Logic)

      Read this article for free

      By entering your e-mail you consent to receiving commercial electronic messages from The Logic Inc. containing news, updates, offers or promotions about The Logic Inc.’s products and services. You can withdraw your consent at anytime. Please refer to our privacy policy or contact us for more details.
      Already a subscriber?